Gastrointestinal comorbidities associated with atrial fibrillation
Open Access
- 15 October 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in SpringerPlus
- Vol. 3 (1), 1-9
- https://doi.org/10.1186/2193-1801-3-603
Abstract
This observational study was conducted to describe the risk of gastrointestinal (GI) events among patients with atrial fibrillation (AF). We analyzed Thomson Reuters MarketScan® data from 2005 to 2009. Subjects aged ≥18 years with ≥ 1 AF diagnosis were selected. GI events were identified from claims with a primary or secondary diagnosis code for any GI condition. The risk of GI events was assessed using cumulative incidence (new GI events/patients with AF without GI condition at baseline) and incidence rates (IRs), calculated as the number of patients with new GI events divided by patient-years of observation. In addition, the CHADS2 score was evaluated at baseline to determine the patient’s risk of stroke. A total of 557,123 AF patients were identified. The mean (median) AF patient age was 68.2 years (70); 45% were female. The cumulative incidences of any GI event and dyspepsia were 40% and 19%, respectively. The corresponding IRs were 38.8 and 14.7 events per 100 patient–years. IRs of any GI events for female and male patients were 43.6 and 35.5; for patients in the age groups 2 score of 0, 1–2, 3–4, and 5–6, IRs were 30.3, 41.6, 56.9, and 74.5, respectively. In this large claims database, 40% of AF patients experienced a GI event, predominantly dyspepsia. Physicians should take age and comorbidities into consideration when managing AF patients.Keywords
This publication has 39 references indexed in Scilit:
- Gastroesophageal Reflux Disease and Atrial Fibrillation: A Nationwide Population-Based StudyPLOS ONE, 2012
- Dyspepsia and Disease Burden Among Patients With Atrial FibrillationCritical Pathways in Cardiology: A Journal of Evidence-Based Medicine, 2012
- Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 2011
- Novel opioid antagonists for opioid-induced bowel dysfunctionExpert Opinion on Investigational Drugs, 2011
- Pooled analysis of GI tolerability of 21 randomized controlled trials of celecoxib and nonselective NSAIDsCurrent Medical Research and Opinion, 2009
- Warfarin With Fluoroquinolones, Sulfonamides, or Azole Antifungals: Interactions and the Risk of Hospitalization for Gastrointestinal BleedingClinical Pharmacology & Therapeutics, 2008
- Polypharmacy in elderly patientsThe American Journal of Geriatric Pharmacotherapy, 2007
- Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control studyBMJ, 2006
- A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)The Lancet, 1996
- Nonsteroidal antiinflammatory drugs and dyspepsia in the elderlyDigestive Diseases and Sciences, 1995